Board Stats

Alnylam Pharmaceuticals

We have set up a new board (#AdminHowTo) to better assist you with using our service and getting the most out of it.

To access the board, click the blue link above or, if you are a registered member, you can check the latest message from Admin in your IV Inbox and click the link provided there as well.

Y! Homepage #ALNY @ Stocktwits @Alnylam (Company Twitter Account) ALNY @ LinkedIn ALNY YouTube Channel ALNY @ BioPharmaCatalyst.com $ALNY stream @ Twitter

ALNY / Message Board

BOARD

GROUPS

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
35016	Re: JM leaving - another Endpoints article	GN	arthurs1		0	11/6/2021 6:32:21 PM

35015	Today's PR - Lumasiran Resulted in Substantial Reductions in Plasma Oxalate in PH1 Patients with Severe Renal Impairment	GN	Steve_382		0	11/5/2021 2:22:05 PM

35014	Re: VIR update 8-K for earnings report Q3 2021	GN	Steve_382		0	11/4/2021 4:16:12 PM

35013	New study on hypertension up at Clinical Trials site.	GN	Steve_382		0	11/2/2021 12:47:12 PM

35012	Re: JM leaving - another Endpoints article	GN	Steve_382		0	10/29/2021 9:03:58 AM

35011	Re: JM leaving	GN	evernewbliss		1	10/28/2021 2:49:42 PM

35010	Re: JM leaving - Endpoints article also	GN	Steve_382		1	10/28/2021 11:48:39 AM

35009	Re: JM leaving	GN	sherk		1	10/28/2021 10:54:28 AM

35008	JM leaving	GN	Steve_382		0	10/28/2021 8:18:57 AM

35007	Vutrisiran Update	GN	Steve_382		0	10/27/2021 4:06:21 PM

Go to Msg #

BOARDS Sign In for Filters